tinidazole

Also known as Symplotan, CP-12574, Trimonase, Tindamax, Timidazole, Fasigyn

Tinidazole, sold under the brand name Tindamax among others, is a medication used against infections caused by certain anaerobic bacteria and protozoa. It was developed in 1972 and is a prominent member of the nitroimidazole antibiotic class.

In the Vinony graph

Vinony's link graph records 135 inbound references to tinidazole, and connects out to antibiotic, paromomycin and oxyquinoline.

It sits within the topics Antiprotozoal agents, Disulfiram-like drugs and ECHA InfoCard ID from Wikidata.

Vinony links it to 24 Wikipedia language editions.

Key facts

Drug.N: 3
Drug.verifiedrevid: 470610559
Drug.image: Tinidazole.svg
Drug.image_class: skin-invert-image
Drug.width: 160
Drug.image2: Tinidazole ball-and-stick model from xtal 2020.png
Drug.image_class2: bg-transparent
Drug.tradename: Tindamax, others
Drug.MedlinePlus: a604036
Drug.DailyMedID: Tinidazole
Drug.pregnancy_AU: B3
Drug.routes_of_administration: By mouth
Drug.ATC_prefix: J01
Drug.ATC_suffix: XD02
Drug.ATC_supplemental: , , , , , ,
Drug.legal_AU: S4
Drug.legal_UK: POM
Drug.legal_US: Rx-only

via Wikipedia infobox

Chemical data

Formula: C8H13N3O4S
Molecular weight: 247.27 g/mol
IUPAC name: 1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole
SMILES: CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C
InChIKey: HJLSLZFTEKNLFI-UHFFFAOYSA-N
XLogP: -0.4
Polar surface area: 106 Å²
H-bond donors: 0
H-bond acceptors: 5
Formal charge: 0

via PubChem

Drug data · ChEMBL

Max clinical phase: Approved
Molecule type: Small molecule
First approval: 2004
Admin. routes: oral
Indications: bacterial vaginosis, trichomoniasis, Plasmodium vivax malaria, urethritis

via ChEMBL · EBI